Drug costs

Prostate Cancer drugs cost more in the USA than in other countries.

The cost of Enzalutamide (Xtandi) in the United States is being challenged by Knowledge Ecology International (KEI), a public interest advocacy group. The average US wholesale price of Xtandi in 2015 was $88 per capsule. That can add up to $129,000 annual cost per man. There are significant issues related to high costs of treatment. [...]

By Malecare|2021-02-17T10:41:27-05:00May 5th, 2016|Advanced Prostate Cancer, Advocacy, Disparities, Drugs & Treatments, enzalutamide, Insurance, NIH, Politics of Cancer, Uncategorized, United States, Xtandi|0 Comments

Understanding and Trying to Rectify the Abusive Costs of Our Drugs

I have been relatively quiet about the skyrocketing cost of drugs, but it has now become impossible to remain out of the fray. A Pharmaceutical company recently acquired a drug called Daraprim, the drug treats potentially fatal parasitic infections. After its acquisition the company raised the price of Daraprim by almost 5,0000%. When confronted with [...]

By Malecare|2017-10-19T10:46:55-04:00September 28th, 2015|